 |
Diabetes
UK and South Asian Health Foundation recommendations on diabetes
research priorities for British South Asians |
| |
Diabetes UK and the South Asian Health Foundation
have worked together on this review, whose principal purpose is
to highlight the gaps in our understanding of diabetes in the UK-based
South Asian population as well as to identify recommendations and
priorities for future research areas. 123-page PDF (SAHF) |
| |
|
|
Diabetes
UK pinpoints key research in South Asian people |
| |
Diabetes UK and the South Asian Health Foundation
(SAHF) are highlighting 16 research topics in a new report to find
out more about diabetes in South Asian people (Diabetes UK) |
| |
|
|
Diabetes
Care Quality Improvement |
| |
A Resource Guide for State Action (Agency for
Healthcare Research and Quality, USA) |
| |
|
|
Diabetes
rates on the rise, developing countries seek solution |
| |
Populous India and China have the most diabetic
citizens in the world, with 40.9 million and 39.8 million respectively
(Scientific American) |
| |
|
|
Diabetic
Neuropathy |
| |
An update from (Joslin Diabetes, USA) |
| |
|
|
Population-based
incidence of Type 2 diabetes and its associated risk factors:
results from a six-year cohort study in Iran |
| |
This study aimed to estimate Type 2 diabetes
incidence and its associated risk factors in an Iranian urban population
(7th Space) |
| |
|
|
Commencing
insulin – what the patient needs to know |
| |
Psychological insulin resistance is an epidemic
among individuals with type 2 diabetes. But it’s also a problem with health professionals (RACGP) |
| |
|
|
Efficacy
of a continuous GLP-1 infusion compared to a structured insulin
infusion protocol |
| |
GLP-1 infusion is superior to an established
insulin infusion regimen with regard to effectiveness and practicability
(Diabetes Care) |
| |
|
|
Cannabis
used in diabetes medicine |
| |
Drugs for treating diabetes could be developed
using cannabis plant extracts, a leading scientist in the field
has said (Pharmacy Europe) |
| |
|
|
Addressing
Patient Challenges to Diabetes Treatment Through the Use of Incretin-based
Therapies |
| |
In this text-based programme, based on a symposium
conducted during a meeting of the American Pharmacists Association,
the authors discuss patient challenges in the management of type
2 diabetes, and identify patients who may benefit from incretin-based
therapies (Doctors Guide) |
| |
|
|
News
feed |
| |
We are inviting expressions of interest from
organisations who wish to commission a news feed for their website
(Editor) |
| |
|
